awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50917782-F2A4CBE4-533A-435E-B7B6-137798EB7B22
Q50917782-F2A4CBE4-533A-435E-B7B6-137798EB7B22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50917782-F2A4CBE4-533A-435E-B7B6-137798EB7B22
Extension of the Calvert formula to patients with severe renal insufficiency.
P2860
Q50917782-F2A4CBE4-533A-435E-B7B6-137798EB7B22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50917782-F2A4CBE4-533A-435E-B7B6-137798EB7B22
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3acc0054eb40b0eae2b856046c2133677d4b932
P2860
Phase I dose-escalation study and population pharmacokinetic analysis of fixed dose rate gemcitabine plus carboplatin as second-line therapy in patients with ovarian cancer.